Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 1383

BillFederalSenateIn Committee
Dextromethorphan Abuse Reduction Act of 2009
About This Bill
Committee
Latest Action · June 25, 2009
Read twice and referred to the Committee on the Judiciary. (text of measure as introduced: CR S7098-7099)
Congress
111th (2009–2011)
Introduced
June 25, 2009
Cosponsors (1)
0D 1R
View PDF ↗

Summary

Highlight any text to annotate
Dextromethorphan Abuse Reduction Act of 2009 - Amends the Controlled Substances Act to prohibit sales of products containing dextromethorphan (including cough medicines) to individuals under age 18, including sales using the Internet, and to impose civil penalties for such sales. Directs the Director of National Drug Control Policy to provide grants to certain nonprofit drug prevention entities, including the National Community Antidrug Coalition Institute, for antidrug educational campaigns aimed at individuals under age 18 and for assistance to community antidrug coalitions to prevent abuse of prescription and nonprescription drugs (including dextromethorphan). Directs the Administrator of the Substance Abuse and Mental Health Services Administration of the Department of Health and Human Services (HHS) to make grants to implement comprehensive community-wide strategies for preventing abuse of prescription and nonprescription drugs (including dextromethorphan).

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.